US20060128795A1 - Agents for promoting fattening of animals and method of promoting fattening - Google Patents
Agents for promoting fattening of animals and method of promoting fattening Download PDFInfo
- Publication number
- US20060128795A1 US20060128795A1 US11/341,448 US34144806A US2006128795A1 US 20060128795 A1 US20060128795 A1 US 20060128795A1 US 34144806 A US34144806 A US 34144806A US 2006128795 A1 US2006128795 A1 US 2006128795A1
- Authority
- US
- United States
- Prior art keywords
- composition
- acid
- gluconate
- feed
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 241001465754 Metazoa Species 0.000 title abstract description 36
- 230000001737 promoting effect Effects 0.000 title abstract description 15
- 238000000034 method Methods 0.000 title abstract description 8
- 239000002253 acid Substances 0.000 claims abstract description 30
- 150000003839 salts Chemical class 0.000 claims abstract description 12
- 231100000252 nontoxic Toxicity 0.000 claims abstract description 8
- 230000003000 nontoxic effect Effects 0.000 claims abstract description 8
- AEQDJSLRWYMAQI-UHFFFAOYSA-N 2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3CC2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-UHFFFAOYSA-N 0.000 claims description 44
- 239000000176 sodium gluconate Substances 0.000 claims description 44
- 235000012207 sodium gluconate Nutrition 0.000 claims description 44
- 229940005574 sodium gluconate Drugs 0.000 claims description 44
- 239000000203 mixture Substances 0.000 claims description 26
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 claims description 18
- 235000002639 sodium chloride Nutrition 0.000 claims description 16
- -1 alkali metal salt Chemical class 0.000 claims description 14
- 239000000654 additive Substances 0.000 claims description 12
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 claims description 10
- 230000000996 additive effect Effects 0.000 claims description 10
- 239000000174 gluconic acid Substances 0.000 claims description 10
- 235000012208 gluconic acid Nutrition 0.000 claims description 10
- 235000012054 meals Nutrition 0.000 claims description 10
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 claims description 9
- 239000003242 anti bacterial agent Substances 0.000 claims description 7
- 235000019197 fats Nutrition 0.000 claims description 7
- 235000012209 glucono delta-lactone Nutrition 0.000 claims description 7
- 239000000182 glucono-delta-lactone Substances 0.000 claims description 7
- 229960003681 gluconolactone Drugs 0.000 claims description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 6
- 241000604448 Megasphaera elsdenii Species 0.000 claims description 6
- 241000509622 Mitsuokella multacida Species 0.000 claims description 6
- 240000008042 Zea mays Species 0.000 claims description 6
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 6
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 6
- 239000004227 calcium gluconate Substances 0.000 claims description 6
- 235000013927 calcium gluconate Nutrition 0.000 claims description 6
- 229960004494 calcium gluconate Drugs 0.000 claims description 6
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 claims description 6
- 235000005822 corn Nutrition 0.000 claims description 6
- 239000008103 glucose Substances 0.000 claims description 6
- 241000604449 Megasphaera Species 0.000 claims description 5
- 241000509624 Mitsuokella Species 0.000 claims description 5
- 244000005700 microbiome Species 0.000 claims description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 4
- 240000007594 Oryza sativa Species 0.000 claims description 4
- 235000007164 Oryza sativa Nutrition 0.000 claims description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 4
- 241000209140 Triticum Species 0.000 claims description 4
- 235000021307 Triticum Nutrition 0.000 claims description 4
- 239000001506 calcium phosphate Substances 0.000 claims description 4
- 235000009566 rice Nutrition 0.000 claims description 4
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 4
- 244000068988 Glycine max Species 0.000 claims description 3
- 235000010469 Glycine max Nutrition 0.000 claims description 3
- 235000013339 cereals Nutrition 0.000 claims description 3
- 239000003925 fat Substances 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- RGHNJXZEOKUKBD-TXICZTDVSA-N (2r,3r,4r,5r)-2,3,4,5,6-pentahydroxyhexanoic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-TXICZTDVSA-N 0.000 claims description 2
- RGHNJXZEOKUKBD-STGXQOJASA-N (2s,3s,4s,5r)-2,3,4,5,6-pentahydroxyhexanoic acid Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)[C@H](O)C(O)=O RGHNJXZEOKUKBD-STGXQOJASA-N 0.000 claims description 2
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 claims description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- 235000019743 Choline chloride Nutrition 0.000 claims description 2
- 229920002261 Corn starch Polymers 0.000 claims description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 2
- RGHNJXZEOKUKBD-MGCNEYSASA-N D-galactonic acid Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-MGCNEYSASA-N 0.000 claims description 2
- DSLZVSRJTYRBFB-LLEIAEIESA-N D-glucaric acid Chemical compound OC(=O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O DSLZVSRJTYRBFB-LLEIAEIESA-N 0.000 claims description 2
- DSLZVSRJTYRBFB-LDHWTSMMSA-N D-mannaric acid Chemical compound OC(=O)[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O DSLZVSRJTYRBFB-LDHWTSMMSA-N 0.000 claims description 2
- 102000004190 Enzymes Human genes 0.000 claims description 2
- 108090000790 Enzymes Proteins 0.000 claims description 2
- 235000019733 Fish meal Nutrition 0.000 claims description 2
- 108010010803 Gelatin Proteins 0.000 claims description 2
- 108010068370 Glutens Proteins 0.000 claims description 2
- 240000005979 Hordeum vulgare Species 0.000 claims description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 2
- 240000004658 Medicago sativa Species 0.000 claims description 2
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 claims description 2
- HLCFGWHYROZGBI-JJKGCWMISA-M Potassium gluconate Chemical compound [K+].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O HLCFGWHYROZGBI-JJKGCWMISA-M 0.000 claims description 2
- 235000019484 Rapeseed oil Nutrition 0.000 claims description 2
- 240000006394 Sorghum bicolor Species 0.000 claims description 2
- 235000011684 Sorghum saccharatum Nutrition 0.000 claims description 2
- 229920002472 Starch Polymers 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- 235000009430 Thespesia populnea Nutrition 0.000 claims description 2
- 239000005862 Whey Substances 0.000 claims description 2
- 102000007544 Whey Proteins Human genes 0.000 claims description 2
- 108010046377 Whey Proteins Proteins 0.000 claims description 2
- 229910052783 alkali metal Inorganic materials 0.000 claims description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims description 2
- 239000010775 animal oil Substances 0.000 claims description 2
- 229940121375 antifungal agent Drugs 0.000 claims description 2
- 239000003429 antifungal agent Substances 0.000 claims description 2
- 239000003963 antioxidant agent Substances 0.000 claims description 2
- 235000015278 beef Nutrition 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 2
- 229960003563 calcium carbonate Drugs 0.000 claims description 2
- 235000010216 calcium carbonate Nutrition 0.000 claims description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 claims description 2
- 235000011010 calcium phosphates Nutrition 0.000 claims description 2
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 claims description 2
- 229960003178 choline chloride Drugs 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims description 2
- 239000008120 corn starch Substances 0.000 claims description 2
- 239000010685 fatty oil Substances 0.000 claims description 2
- 210000003746 feather Anatomy 0.000 claims description 2
- 239000004467 fishmeal Substances 0.000 claims description 2
- 235000013312 flour Nutrition 0.000 claims description 2
- 235000011194 food seasoning agent Nutrition 0.000 claims description 2
- 239000008273 gelatin Substances 0.000 claims description 2
- 229920000159 gelatin Polymers 0.000 claims description 2
- 235000019322 gelatine Nutrition 0.000 claims description 2
- 235000011852 gelatine desserts Nutrition 0.000 claims description 2
- 235000021312 gluten Nutrition 0.000 claims description 2
- 235000011187 glycerol Nutrition 0.000 claims description 2
- 239000008101 lactose Substances 0.000 claims description 2
- 235000013379 molasses Nutrition 0.000 claims description 2
- 239000003921 oil Substances 0.000 claims description 2
- 235000019198 oils Nutrition 0.000 claims description 2
- 239000004224 potassium gluconate Substances 0.000 claims description 2
- 235000013926 potassium gluconate Nutrition 0.000 claims description 2
- 229960003189 potassium gluconate Drugs 0.000 claims description 2
- 235000020183 skimmed milk Nutrition 0.000 claims description 2
- 239000011780 sodium chloride Substances 0.000 claims description 2
- 229960002668 sodium chloride Drugs 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 239000000600 sorbitol Substances 0.000 claims description 2
- 235000012424 soybean oil Nutrition 0.000 claims description 2
- 239000003549 soybean oil Substances 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- 239000003760 tallow Substances 0.000 claims description 2
- 229910052723 transition metal Inorganic materials 0.000 claims description 2
- 229940078499 tricalcium phosphate Drugs 0.000 claims description 2
- 229910000391 tricalcium phosphate Inorganic materials 0.000 claims description 2
- 235000019731 tricalcium phosphate Nutrition 0.000 claims description 2
- 239000003981 vehicle Substances 0.000 claims description 2
- 229940088594 vitamin Drugs 0.000 claims description 2
- 239000011782 vitamin Substances 0.000 claims description 2
- 229930003231 vitamin Natural products 0.000 claims description 2
- 235000013343 vitamin Nutrition 0.000 claims description 2
- 235000019737 Animal fat Nutrition 0.000 claims 1
- 240000002791 Brassica napus Species 0.000 claims 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 claims 1
- OCUCCJIRFHNWBP-IYEMJOQQSA-L Copper gluconate Chemical compound [Cu+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OCUCCJIRFHNWBP-IYEMJOQQSA-L 0.000 claims 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims 1
- 239000000921 anthelmintic agent Substances 0.000 claims 1
- 230000003078 antioxidant effect Effects 0.000 claims 1
- 229940108925 copper gluconate Drugs 0.000 claims 1
- 229910017053 inorganic salt Inorganic materials 0.000 claims 1
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical compound [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 claims 1
- 239000001755 magnesium gluconate Substances 0.000 claims 1
- 235000015778 magnesium gluconate Nutrition 0.000 claims 1
- 229960003035 magnesium gluconate Drugs 0.000 claims 1
- IAKLPCRFBAZVRW-XRDLMGPZSA-L magnesium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;hydrate Chemical compound O.[Mg+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O IAKLPCRFBAZVRW-XRDLMGPZSA-L 0.000 claims 1
- 150000003722 vitamin derivatives Chemical class 0.000 claims 1
- 239000011670 zinc gluconate Substances 0.000 claims 1
- 235000011478 zinc gluconate Nutrition 0.000 claims 1
- 229960000306 zinc gluconate Drugs 0.000 claims 1
- 150000007513 acids Chemical class 0.000 abstract description 21
- 239000003795 chemical substances by application Substances 0.000 abstract description 16
- 150000002402 hexoses Chemical class 0.000 abstract description 16
- 239000004480 active ingredient Substances 0.000 abstract description 4
- 230000032050 esterification Effects 0.000 abstract 1
- 238000005886 esterification reaction Methods 0.000 abstract 1
- 230000037396 body weight Effects 0.000 description 21
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 18
- 230000000052 comparative effect Effects 0.000 description 13
- 238000006243 chemical reaction Methods 0.000 description 12
- 235000020188 drinking water Nutrition 0.000 description 12
- 239000003651 drinking water Substances 0.000 description 12
- 241000287828 Gallus gallus Species 0.000 description 11
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 10
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 9
- 241000305071 Enterobacterales Species 0.000 description 9
- 150000004666 short chain fatty acids Chemical class 0.000 description 9
- 235000021391 short chain fatty acids Nutrition 0.000 description 9
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 8
- 241000282887 Suidae Species 0.000 description 8
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 8
- 229940050410 gluconate Drugs 0.000 description 8
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 8
- 229910052708 sodium Inorganic materials 0.000 description 8
- 239000011734 sodium Substances 0.000 description 8
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 7
- 235000021050 feed intake Nutrition 0.000 description 7
- 239000007789 gas Substances 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 6
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 229940088710 antibiotic agent Drugs 0.000 description 5
- 235000013330 chicken meat Nutrition 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 239000004310 lactic acid Substances 0.000 description 4
- 235000014655 lactic acid Nutrition 0.000 description 4
- 235000019260 propionic acid Nutrition 0.000 description 4
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 4
- 239000008399 tap water Substances 0.000 description 4
- 235000020679 tap water Nutrition 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 3
- 241000238557 Decapoda Species 0.000 description 3
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 239000001530 fumaric acid Substances 0.000 description 3
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000001384 succinic acid Substances 0.000 description 3
- 235000011044 succinic acid Nutrition 0.000 description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 241000286209 Phasianidae Species 0.000 description 2
- 235000013527 bean curd Nutrition 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229960005069 calcium Drugs 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- XYHKNCXZYYTLRG-UHFFFAOYSA-N 1h-imidazole-2-carbaldehyde Chemical compound O=CC1=NC=CN1 XYHKNCXZYYTLRG-UHFFFAOYSA-N 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-M 3-Methylbutanoic acid Natural products CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 description 1
- 208000010444 Acidosis Diseases 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 241000252073 Anguilliformes Species 0.000 description 1
- 241000272517 Anseriformes Species 0.000 description 1
- 241000269350 Anura Species 0.000 description 1
- 241000473391 Archosargus rhomboidalis Species 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 239000004184 Avoparcin Substances 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000282414 Homo sapiens Species 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000282339 Mustela Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 241000277331 Salmonidae Species 0.000 description 1
- 241000276699 Seriola Species 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 241001441724 Tetraodontidae Species 0.000 description 1
- 241001504592 Trachurus trachurus Species 0.000 description 1
- 241001482311 Trionychidae Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- KPKHVFGABLTMTR-UHFFFAOYSA-N acetic acid;butanedioic acid;2-hydroxypropanoic acid Chemical compound CC(O)=O.CC(O)C(O)=O.OC(=O)CCC(O)=O KPKHVFGABLTMTR-UHFFFAOYSA-N 0.000 description 1
- 230000007950 acidosis Effects 0.000 description 1
- 208000026545 acidosis disease Diseases 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000019377 avoparcin Nutrition 0.000 description 1
- JWFVWARSGMYXRN-HTQQBIQNSA-N avoparcin Chemical compound O([C@H]1[C@H](C(N[C@H](C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(N[C@H](C4=CC(O)=CC(O)=C4C=4C(O)=CC=C3C=4)C(O)=O)=O)CC3=C(O[C@@H]4O[C@@H](C)[C@H](O)[C@H](N)C4)C=C(C(=C3)Cl)OC=3C=C2C=C(C=3O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O[C@@H]2O[C@@H](C)[C@H](O)[C@H](N)C2)OC2=CC=C1C=C2)C=1C=CC(O)=CC=1)=O)NC(=O)[C@@H](NC)C=1C=CC(O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)=CC=1)[C@@H]1O[C@@H](CO)[C@H](O)[C@@H](O)[C@H]1O JWFVWARSGMYXRN-HTQQBIQNSA-N 0.000 description 1
- 229950001335 avoparcin Drugs 0.000 description 1
- 108010053278 avoparcin Proteins 0.000 description 1
- YNTQKXBRXYIAHM-UHFFFAOYSA-N azanium;butanoate Chemical compound [NH4+].CCCC([O-])=O YNTQKXBRXYIAHM-UHFFFAOYSA-N 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N beta-methyl-butyric acid Natural products CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 229920005549 butyl rubber Polymers 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 229940069978 calcium supplement Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000000701 coagulant Substances 0.000 description 1
- 229910000361 cobalt sulfate Inorganic materials 0.000 description 1
- 229940044175 cobalt sulfate Drugs 0.000 description 1
- KTVIXTQDYHMGHF-UHFFFAOYSA-L cobalt(2+) sulfate Chemical compound [Co+2].[O-]S([O-])(=O)=O KTVIXTQDYHMGHF-UHFFFAOYSA-L 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- 229960000355 copper sulfate Drugs 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- RSAZYXZUJROYKR-UHFFFAOYSA-N indophenol Chemical compound C1=CC(O)=CC=C1N=C1C=CC(=O)C=C1 RSAZYXZUJROYKR-UHFFFAOYSA-N 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229910000358 iron sulfate Inorganic materials 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- 229960004839 potassium iodide Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 229940005605 valeric acid Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/105—Aliphatic or alicyclic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/121—Heterocyclic compounds containing oxygen or sulfur as hetero atom
- A23K20/126—Lactones
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
- A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S426/00—Food or edible material: processes, compositions, and products
- Y10S426/807—Poultry or ruminant feed
Definitions
- the present invention relates to an agent for promoting the fattening of animals and to a method for promoting the fattening of animals. More precisely, the invention relates to an agent for promoting the fattening of animals, which contains, as an active ingredient, at least one of hexose-derived acids such as typically gluconic acid, and their non-toxic salts and intramolecular ester compounds, and to a method of promoting the fattening of animals by use thereof.
- antibiotics such as tetracycline and avoparcin have heretofore been used by being added to feed as fattening promoters.
- these antibiotics often induce resistant bacteria through mutation in the body of animals.
- they may remain in the body of animals, and the human beings who have eaten the meat of the animals shall inevitably take the antibiotics.
- the potency of antibiotics serving as medicines will be thereby lowered.
- gluconic acid which is one typical example of hexose-derived acids has heretofore been widely used.
- glucono delta lactone is known as a coagulant for tofu (soybean curd); and calcium gluconate is known as a calcium supplement.
- sodium gluconate and potassium gluconate have been officially approved as food additives recently and are used in various edibles (International Patent No. WO94/09650).
- the inventors of the present invention have tried administering gluconic acid and its derivatives, which are highly safe to living bodies, to animals and analyzing their activity to the living bodies. Having specifically examined their effect in the animal intestines, the inventors have found unexpectedly that they promote the growth of specific enterobacteria in the animals and that the thus-growing enterobacteria significantly increase the production of short-chain fatty acids which are effective for the growth of the living bodies. In addition, the inventors have further found that the production of substances that will be harmful to living bodies is reduced or eliminated.
- hexose-derived acids and their non-toxic salts and intramolecular ester compounds are administered to animals, Megasphaera and Mitsuokella , precisely Megasphaera elsdenii and Mitsuokella multiacidus , among enterobacteria in the animals are specifically proliferated.
- the hexose-derived acids are given to animals, the production of short-chain fatty acids is promoted in the living bodies of the animals, and, as a result, the feed efficiency is improved remarkably and the fattening of the animals is thereby accelerated.
- FIG. 1 is a graph showing the results of Test Example 1.
- FIG. 2 is a graph showing the results of Test Example 4.
- the hexose-derived acids in the invention may be any of D-forms, L-forms or their mixtures.
- they include saccharic acids such as glucaric acid, mannaric acid, gularic acid, idalic acid, etc.; and aldonic acids such as gluconic acid, galactonic acid, mannoic acid, talonic acid, allonic acid, etc., of which gluconic acid is especially preferred.
- non-toxic salts of these acids include, for example, salts thereof with alkali metals such as sodium or potassium, salts thereof with alkaline earth metals such as calcium or magnesium, and salts thereof with transition metals such as copper, iron or zinc, of which sodium gluconate and calcium gluconate are especially preferred.
- the intramolecular ester compounds of the acids are, for example, lactone compounds.
- intramolecular ester compounds of gluconic acid such as glucono delta lactone, glucono gamma lactone, of which glucono delta lactone is especially preferred.
- hexose-derived acids may be used alone or as an optional combination of two or more thereof.
- short-chain fatty acids may be mentioned fatty acids having two to four carbon atoms such as acetic acid, propionic acid, butyric acid, isobutyric acid, valeric acid, isovaleric acid, caprylic acid, etc. Lactic acid and succinic acid which differ from these acids in their intracorporeal absorption mechanism and in their influences on living bodies are not included within the scope of the short-chain fatty acids in the present invention.
- improvement of feed efficiency essentially means that even poorly-nutritious animal feed prepared from poor-quality cereals can attain almost the same level of fattening-promoting effect as that of highly-nutritious high-quality feed by addition of any of the hexose-derived acids thereto, but it also means that, when any of the hexose-derived acids is added to highly-nutritious feed, the feed attains a more elevated fattening-promoting effect.
- hexose-derived acids may be used as they are, but may be combined with solid or liquid vehicles well known in the art such as lactose, sucrose, glucose, corn starch, gelatin, starch, water, glycerin, fatty oil, sorbitol and the like to be used as agents for promoting the fattening of animals, agents for promoting the growth of animal enterobacteria, and agents for inhibiting the production of intracorporeal harmful substances.
- solid or liquid vehicles well known in the art such as lactose, sucrose, glucose, corn starch, gelatin, starch, water, glycerin, fatty oil, sorbitol and the like to be used as agents for promoting the fattening of animals, agents for promoting the growth of animal enterobacteria, and agents for inhibiting the production of intracorporeal harmful substances.
- agents may be optionally mixed with ordinary additives such as antibacterial agents, antifungal agents, anthelminthics, antioxidants, dyes, flavorings, seasonings and enzymes, and may be prepared in the form of powders, dispersions, granules, liquid, tablets and the like by conventional methods.
- the agents may be administered to animals as they are, or may be added to feed or drinking water to be taken by animals. Preferably, they are blended to feed or drinking water for animals.
- the feed and drinking water may be any that is ordinary used, and is not particularly limited.
- the feed include corn, rice, barley, wheat, milo, soybean refuse, cereal bran, defatted rice bran, fish meal, skim milk, dry whey, oil, fat, alfalfa meal, northern-sea meal, soybean oil and fat, dried pure beef tallow, wheat flour, rapeseed oil and fat, feather meal, animal oil and fat, calcium phosphate, corn gluten meal, molasses, corn germ meal, calcium carbonate, tricalcium phosphate, sodium chloride, choline chloride, vitamins (vitamin A, vitamin B 1 , vitamin B 2 , vitamin B 6 , vitamin B 12 , vitamin D, vitamin E, calcium pantothenate, nicotinamide, folic acid, etc.), amino acids (lysine, methionine, etc.), minor inorganic salts (magnesium sulfate, iron sulfate, copper sulfate, zinc sul
- the dose of the hexose-derived acids varies depending on the species and the body weight of animals to which they are applied, but generally falls between 20 and 1300 mg/kg/day, preferably between 20 and 600 mg/kg/day.
- the hexose-derived acids may generally be used as active ingredients in a proportion between 0.05 and 2.0% by weight (“%” is hereinafter % by weight), preferably between 0.1 and 1.0%.
- the invention also provides a method for raising animals by administering an agent as mentioned above to animals or by feeding animals with feed or drinking water that contains the agent.
- the method is applicable to any ordinary livestock including, for example, cattle, pigs, horses, sheep, goats, rabbits, minks, chickens, turkeys, domestic ducks, quails, wild ducks, soft-shelled turtles, frogs, lobsters, prawns, shrimps, yellowtails, sea breams, globefishes, eels, salmon, trout, horse mackerels, etc. It is preferably applied especially to cattle, pigs or chickens.
- An agents according to the invention and the feed or drinking water containing it may be administered or fed to these animals in ordinary manners.
- enterobacteria such as Megasphaera and Mitsuokella may be administered directly to animals, for example, in the form of a dry preparation. This is expected to further enhance the promotion of the growth of enterobacteria followed by the promotion of the fattening of animals.
- Example 2 To the feed for pigs (Colomeal GS, a Nippai feed mixture for raising suckling-stage piglets, manufactured by Nippon Haigo Shiryo), added were 0.125% (Example 2), 0.25% (Example 3), 0.5% (Example 4) and 1.0% (Example 5), relative to the weight of the feed, of sodium gluconate.
- the feed for pigs (Colomeal GS, a Nippai feed mixture for raising suckling-stage piglets, manufactured by Nippon Haigo Shiryo) itself was used as feed.
- Examples 1 to 5 and Comparative Examples 1 and 2 were fed to groups of piglets (about 35-day-old hybrid piglets), each group being composed of 4 piglets (2 male piglets and 2 female piglets), continuously for 4 weeks.
- the piglets were weighed individually, and an increase in the body weight was calculated for each group.
- checked was the feed intake during the period between the days on which the body weight was measured, and the feed conversion ratio was calculated from the overall body weight increase and the overall feed intake. The test was repeated 4 times, and the body weight increases and feed conversion ratios obtained 4 times were averaged for every group.
- the body weight of the piglets increased by 2 to 12% and the feed efficiency improved by 5 to 13%, as compared with the cases of the piglets not having taken sodium gluconate.
- Sodium gluconate was added to and dissolved in tap water, the amount of which was such that piglets drank up in 8 hours/day (9:00 to 17:00), in such an amount that sodium gluconate could be taken by test piglets in the same amount as taken when the feed contained 0.5% gluconate (200 mg/kg-body weight/day). During the other hours, tap water not containing sodium gluconate was given. This cycle was repeated.
- the feed for piglets (“Kobuta Tonton”, a feed mixture for raising piglets, manufactured by Nippon Haigo Shiryo) itself was used as feed.
- Example 9 The feeds of Examples 6 to 8 and Comparative Example 3 and the drinking water of Example 9 were fed to groups of piglets (about 2-month-old ter-hybrid piglets), each group being composed of 6 piglets (3 male piglets and 3 female piglets), continuously for 8 weeks.
- groups of piglets about 2-month-old ter-hybrid piglets
- 6 piglets 3 male piglets and 3 female piglets
- Example 6 sodium gluconate 38.7 (112) 2.77 (92) in feed, 0.5 Example 7 glucono delta 40.8 (118) 2.57 (86) lactone in feed, 0.5 Example 8 calcium 38.2 (110) 2.75 (92) gluconate in feed, 0.5 Example 9 sodium gluconate 38.2 (110) 2.87 (96) in drinking water, 0.5 Comparative sodium gluconate 34.7 (100) 3.00 (100) Example 3 in feed, 0 *Index based on Comparative Example 3 of 100.
- SDB No. 1 and SDB No. 2 standard test feeds for broilers, manufactured by Nippon Haigo Shiryo
- SDB No. 1 and SDB No. 2 both contained 0.1% of sodium gluconate.
- Example 10 and Comparative Example 4 and the drinking water prepared in Example 11 were fed to groups of new born broiler chicks (Chunky), each group being composed of 50 chicks (25 male chicks and 25 female chicks), continuously for 8 weeks.
- Chicks were weighed individually, and an increase in the body weight was calculated for every group.
- checked was the feed intake during the period between the days on which the body weight was measured, and the feed conversion ratio was calculated from the overall body weight increase and the overall feed intake. The results are shown in Table 3.
- the above-mentioned feeds were fed to groups of piglets (body weight: about 20 kg), each group being composed of 4 piglets (2 male piglets and 2 female piglets), continuously for 8 weeks (the feed for latter artificial milk for the former 2 weeks and the feed for raising piglets for the latter 6 weeks).
- each of the piglets was weighed every week, and an increase in the body weight was calculated for every group.
- checked was the feed intake during the period between the days on which the body weight was measured, and the feed conversion ratio was calculated.
- the cultures were pre-treated according to the Ushida and Sakata's conditions (Anim. Sci. Technol., 69, 571-575, 1988), and then were analyzed on the concentration of short-chain fatty acids, succinic acid and lactic acid therein by HPLC and the concentration of ammonia therein by the indophenol method (Weatherburn, Analytic Chem., 39, 971-974, 1967). Subtracting the concentration before cultivation from that after cultivation gives the amount (mM) generated through fermentation. The results are shown in Table 5.
- the concentration of acetic acid, propionic acid and butyric acid in the cultures with sodium gluconate added thereto greatly increased as compared with that in the cultures without sodium gluconate. This increase is comparable or higher as compared with the cultures with glucose added thereto, and in particular, butyric acid was observed to increase significant. Substances which may be harmful such as lactic acid, succinic acid and ammonia were observed to greatly reduce in the cultures with sodium gluconate added thereto.
- the amount of fermentation gas generated in the cultivation of Example 12 was measured by putting a glass syringe equipped with an injection needle into a head space of the serum bottle, sucking the gas until normal pressure is reached and measuring the sucked gas by a syringe scale.
- Pigs were acclimated for 1 week, and the contents of their large intestines were taken out. The contents were diluted 5-fold with an anaerobic phosphate buffer (50 mM, pH 6.5), and then filtrated through 4-layered gauze. One mL of the resulting filtrate was inoculated on a PYF medium (100 mL) with 1 w/v % sodium gluconate added thereto, and incubated in an anaerobic condition at 39° C.
- anaerobic phosphate buffer 50 mM, pH 6.5
- the culture without sodium gluconate and the culture with sodium gluconate added thereto were sampled on 0, 8, 24, 48, 96 and 144 hours in a germ-free condition, and the samples were diluted to 10 ⁇ 5 .
- 0.05 mL of each dilution were inoculated on BL agar media (manufactured by Nissui), and anaerobically incubated at 37° C. for 48 hours. The number of colonies of anaerobic microorganisms having grown in agar plates was counted (Table 7).
- Example 14 The strains Megasphaera elsdenii and Mitsuokella multiacidus having grown in Example 14 were anaerobically incubated in PYF media (100 mL) with 1% w/v sodium gluconate added thereto, at 39° C. for 24 hours. The cultures were analyzed on the concentration of the short-chain fatty acids (mM) therein in the same manner as in Example 12. The results are shown in Table 9.
- the present invention provides an agent for promoting the fattening of animals, which contains, as the active ingredient, at least one of hexose-derived acids and their non-toxic salts and intramolecular ester compounds and also provides a method for promoting the fattening of animals by use of the promoting agent.
- the promoting agent increases enterobacteria, thereby inducing the production only of short-chain fatty acids that are useful for the growth of living things. Consequently, even a poorly-nutritious feed can attain the same level of feed efficiency as that of highly-nutritious feed, and the fattening of animals can be promoted.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Birds (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Physiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Fodder In General (AREA)
- Feed For Specific Animals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Agents for promoting fattening of animals which contain as the active ingredient(s) at least one member selected from among acids originating in hexoses, non-toxic salts thereof and intramolecular esterification products thereof; and a method of promoting fattening by using these agents.
Description
- The present invention relates to an agent for promoting the fattening of animals and to a method for promoting the fattening of animals. More precisely, the invention relates to an agent for promoting the fattening of animals, which contains, as an active ingredient, at least one of hexose-derived acids such as typically gluconic acid, and their non-toxic salts and intramolecular ester compounds, and to a method of promoting the fattening of animals by use thereof.
- For promoting the growth of animals such as livestock, antibiotics such as tetracycline and avoparcin have heretofore been used by being added to feed as fattening promoters. However, these antibiotics often induce resistant bacteria through mutation in the body of animals. In addition, they may remain in the body of animals, and the human beings who have eaten the meat of the animals shall inevitably take the antibiotics. As a result, the potency of antibiotics serving as medicines will be thereby lowered.
- Recently, therefore, substances except antibiotics have been investigated for fattening promoters for animals. For example, fumaric acid is used as a fattening promoter.
- On the other hand, gluconic acid which is one typical example of hexose-derived acids has heretofore been widely used. For example, its intramolecular ester compound, glucono delta lactone is known as a coagulant for tofu (soybean curd); and calcium gluconate is known as a calcium supplement. In addition, sodium gluconate and potassium gluconate have been officially approved as food additives recently and are used in various edibles (International Patent No. WO94/09650).
- The inventors of the present invention have tried administering gluconic acid and its derivatives, which are highly safe to living bodies, to animals and analyzing their activity to the living bodies. Having specifically examined their effect in the animal intestines, the inventors have found unexpectedly that they promote the growth of specific enterobacteria in the animals and that the thus-growing enterobacteria significantly increase the production of short-chain fatty acids which are effective for the growth of the living bodies. In addition, the inventors have further found that the production of substances that will be harmful to living bodies is reduced or eliminated.
- That is, if hexose-derived acids and their non-toxic salts and intramolecular ester compounds (hereinafter the term “hexose-derived acids” generally includes all these compounds) are administered to animals, Megasphaera and Mitsuokella, precisely Megasphaera elsdenii and Mitsuokella multiacidus, among enterobacteria in the animals are specifically proliferated.
- On the other hand, as compared with the absence of the hexose derived acids, the production of acetic acid, propionic acid and butyric acid which are short-chain fatty acids is promoted about 2 times, about 4 times and about 8 times more, respectively. At the same time, the production of lactic acid, succinic acid, ammonia and hydrogen sulfide which are reported to have some negative influences such as diarrhea, digestive tract ulcers, lumen acidosis, etc. on living bodies is reduced or eliminated.
- Therefore, if the hexose-derived acids are given to animals, the production of short-chain fatty acids is promoted in the living bodies of the animals, and, as a result, the feed efficiency is improved remarkably and the fattening of the animals is thereby accelerated.
-
FIG. 1 is a graph showing the results of Test Example 1. -
FIG. 2 is a graph showing the results of Test Example 4. - The hexose-derived acids in the invention may be any of D-forms, L-forms or their mixtures. For example, they include saccharic acids such as glucaric acid, mannaric acid, gularic acid, idalic acid, etc.; and aldonic acids such as gluconic acid, galactonic acid, mannoic acid, talonic acid, allonic acid, etc., of which gluconic acid is especially preferred.
- The non-toxic salts of these acids include, for example, salts thereof with alkali metals such as sodium or potassium, salts thereof with alkaline earth metals such as calcium or magnesium, and salts thereof with transition metals such as copper, iron or zinc, of which sodium gluconate and calcium gluconate are especially preferred.
- The intramolecular ester compounds of the acids are, for example, lactone compounds. For example, mentioned are intramolecular ester compounds of gluconic acid, such as glucono delta lactone, glucono gamma lactone, of which glucono delta lactone is especially preferred.
- These hexose-derived acids may be used alone or as an optional combination of two or more thereof.
- As the short-chain fatty acids, may be mentioned fatty acids having two to four carbon atoms such as acetic acid, propionic acid, butyric acid, isobutyric acid, valeric acid, isovaleric acid, caprylic acid, etc. Lactic acid and succinic acid which differ from these acids in their intracorporeal absorption mechanism and in their influences on living bodies are not included within the scope of the short-chain fatty acids in the present invention.
- The wording “improvement of feed efficiency” essentially means that even poorly-nutritious animal feed prepared from poor-quality cereals can attain almost the same level of fattening-promoting effect as that of highly-nutritious high-quality feed by addition of any of the hexose-derived acids thereto, but it also means that, when any of the hexose-derived acids is added to highly-nutritious feed, the feed attains a more elevated fattening-promoting effect.
- The hexose-derived acids may be used as they are, but may be combined with solid or liquid vehicles well known in the art such as lactose, sucrose, glucose, corn starch, gelatin, starch, water, glycerin, fatty oil, sorbitol and the like to be used as agents for promoting the fattening of animals, agents for promoting the growth of animal enterobacteria, and agents for inhibiting the production of intracorporeal harmful substances.
- These agents may be optionally mixed with ordinary additives such as antibacterial agents, antifungal agents, anthelminthics, antioxidants, dyes, flavorings, seasonings and enzymes, and may be prepared in the form of powders, dispersions, granules, liquid, tablets and the like by conventional methods.
- The agents may be administered to animals as they are, or may be added to feed or drinking water to be taken by animals. Preferably, they are blended to feed or drinking water for animals.
- The feed and drinking water may be any that is ordinary used, and is not particularly limited. Examples of the feed include corn, rice, barley, wheat, milo, soybean refuse, cereal bran, defatted rice bran, fish meal, skim milk, dry whey, oil, fat, alfalfa meal, northern-sea meal, soybean oil and fat, dried pure beef tallow, wheat flour, rapeseed oil and fat, feather meal, animal oil and fat, calcium phosphate, corn gluten meal, molasses, corn germ meal, calcium carbonate, tricalcium phosphate, sodium chloride, choline chloride, vitamins (vitamin A, vitamin B1, vitamin B2, vitamin B6, vitamin B12, vitamin D, vitamin E, calcium pantothenate, nicotinamide, folic acid, etc.), amino acids (lysine, methionine, etc.), minor inorganic salts (magnesium sulfate, iron sulfate, copper sulfate, zinc sulfate, potassium iodide, cobalt sulfate, etc.), living microorganisms, etc., which may be blended and prepared as appropriate.
- The dose of the hexose-derived acids varies depending on the species and the body weight of animals to which they are applied, but generally falls between 20 and 1300 mg/kg/day, preferably between 20 and 600 mg/kg/day. In the case where the hexose-derived acids are added to the feed or drinking water for animals, the hexose-derived acids may generally be used as active ingredients in a proportion between 0.05 and 2.0% by weight (“%” is hereinafter % by weight), preferably between 0.1 and 1.0%.
- The invention also provides a method for raising animals by administering an agent as mentioned above to animals or by feeding animals with feed or drinking water that contains the agent.
- The method is applicable to any ordinary livestock including, for example, cattle, pigs, horses, sheep, goats, rabbits, minks, chickens, turkeys, domestic ducks, quails, wild ducks, soft-shelled turtles, frogs, lobsters, prawns, shrimps, yellowtails, sea breams, globefishes, eels, salmon, trout, horse mackerels, etc. It is preferably applied especially to cattle, pigs or chickens. An agents according to the invention and the feed or drinking water containing it may be administered or fed to these animals in ordinary manners.
- Together with the agent of the invention, enterobacteria such as Megasphaera and Mitsuokella may be administered directly to animals, for example, in the form of a dry preparation. This is expected to further enhance the promotion of the growth of enterobacteria followed by the promotion of the fattening of animals.
- The invention is described in more detail with reference to the following Examples, which, however, are not intended to restrict the scope of the invention.
- To a feed for pigs (Colomeal GS, a Nippai feed mixture for raising suckling-stage piglets, manufactured by Nippon Haigo Shiryo), added were 0.0625%, relative to the weight of the feed, of sodium gluconate.
- To the feed for pigs (Colomeal GS, a Nippai feed mixture for raising suckling-stage piglets, manufactured by Nippon Haigo Shiryo), added were 0.125% (Example 2), 0.25% (Example 3), 0.5% (Example 4) and 1.0% (Example 5), relative to the weight of the feed, of sodium gluconate.
- The feed for pigs (Colomeal GS, a Nippai feed mixture for raising suckling-stage piglets, manufactured by Nippon Haigo Shiryo) itself was used as feed.
- To the feed for pigs (Colomeal GS, a Nichihai feed mixture for raising suckling-stage piglets, manufactured by Nippon Haigo Shiryo), added were 2%, relative to the weight of the feed, of fumaric acid (manufactured by Takeda Chemical Industries Ltd.).
- The feeds of Examples 1 to 5 and Comparative Examples 1 and 2 were fed to groups of piglets (about 35-day-old hybrid piglets), each group being composed of 4 piglets (2 male piglets and 2 female piglets), continuously for 4 weeks. At the start of the feeding test, on two weeks after the start of the test, and at the end of the test, that is, three times in all, the piglets were weighed individually, and an increase in the body weight was calculated for each group. In each group, checked was the feed intake during the period between the days on which the body weight was measured, and the feed conversion ratio was calculated from the overall body weight increase and the overall feed intake. The test was repeated 4 times, and the body weight increases and feed conversion ratios obtained 4 times were averaged for every group. The results are shown in the following Table 1 and
FIG. 1 .TABLE 1 Amount of Mean Body Mean Feed Sodium Amount of Weight Conversion Gluconate Fumaric Acid Increase ± S.D. Ratio ± S.D. Added (%) Added (%) (index*) (index*) Example 1 0.0625 — 14.58 ± 2.42 1.78 ± 0.07 (102) (92) Example 2 0.125 — 14.50 ± 1.95 1.85 ± 0.10 (102) (95) Example 3 0.25 — 14.90 ± 1.87 1.75 ± 0.05 (104) (90) Example 4 0.5 — 15.35 ± 2.26 1.69 ± 0.16 (108) (87) Example 5 1.0 — 15.95 ± 2.97 1.74 ± 0.15 (112) (90) Comp. 0 — 14.28 ± 2.04 1.94 ± 0.12 Example 1 (100) (100) Comp. — 2.0 14.50 ± 2.16 1.85 ± 0.06 Example 2 (102) (96)
*Index based on Comparative Example 1 of 100.
- As shown in the results, in the cases where the piglets were fed with the feeds that contained from 0.0625 to 1.0% of sodium gluconate,
- the body weight of the piglets increased by 2 to 12% and the feed efficiency improved by 5 to 13%, as compared with the cases of the piglets not having taken sodium gluconate.
- To a feed for piglets (“Kobuta Tonton”, a feed mixture for raising piglets, manufactured by Nippon Haigo Shiryo), added were 0.5%, relative to the weight of the feed, of sodium gluconate.
- To the feed for piglets (“Kobuta Tonton”, a feed mixture for raising piglets, manufactured by Nippon Haigo Shiryo), added were 0.5%, relative to the weight of the feed, of glucono delta lactone.
- To the feed for piglets (“Kobuta Tonton”, a feed mixture for raising piglets, manufactured by Nippon Haigo Shiryo), added were 0.5%, relative to the weight of the feed, of calcium gluconate.
- Sodium gluconate was added to and dissolved in tap water, the amount of which was such that piglets drank up in 8 hours/day (9:00 to 17:00), in such an amount that sodium gluconate could be taken by test piglets in the same amount as taken when the feed contained 0.5% gluconate (200 mg/kg-body weight/day). During the other hours, tap water not containing sodium gluconate was given. This cycle was repeated.
- The feed for piglets (“Kobuta Tonton”, a feed mixture for raising piglets, manufactured by Nippon Haigo Shiryo) itself was used as feed.
- The feeds of Examples 6 to 8 and Comparative Example 3 and the drinking water of Example 9 were fed to groups of piglets (about 2-month-old ter-hybrid piglets), each group being composed of 6 piglets (3 male piglets and 3 female piglets), continuously for 8 weeks. At the start of the feeding test, on two weeks, 4 weeks and 6 weeks after the start of the test, and at the end of the test, that is, five times in all, the piglets were weighed individually, and the body weight increase was calculated for every group.
- In each group, checked was the feed intake during the period between the days on which the body weight was measured, and the feed conversion ratio was obtained from the overall body weight increase and the overall feed intake.
- The test was repeated 3 times for Example 6, once for Example 7, once for Examples 8 and 9, and twice for Comparative Example 3, and the obtained body weight increases and feed conversion ratios were averaged for every group. The results are shown in Table 2.
TABLE 2 Type of Additive, Administration Mode, and Mean Body Amount of Weight Increase Mean Feed Additive Added (kg) Conversion Ratio (%) (index*) (index*) Example 6 sodium gluconate 38.7 (112) 2.77 (92) in feed, 0.5 Example 7 glucono delta 40.8 (118) 2.57 (86) lactone in feed, 0.5 Example 8 calcium 38.2 (110) 2.75 (92) gluconate in feed, 0.5 Example 9 sodium gluconate 38.2 (110) 2.87 (96) in drinking water, 0.5 Comparative sodium gluconate 34.7 (100) 3.00 (100) Example 3 in feed, 0
*Index based on Comparative Example 3 of 100.
- As shown in Table 2, in the cases where the piglets were fed with the feeds or the drinking water that contained 0.5% of sodium gluconate, calcium gluconate and glucono delta lactone, the body weight of the piglets increased by 10 to 18% and the feed efficiency improved by 4 to 14%, as compared with the cases of the piglets not having taken the gluconic acid derivatives.
- To a standard test feed for chickens (SDB No. 1 and SDB No. 2, standard test feeds for broilers, manufactured by Nippon Haigo Shiryo), added were 0.5%, relative to the weight of the feed, of sodium gluconate.
- Since chickens drink water in an amount 3 to 4 times larger than the amount of the feed they take, 0.14% of sodium gluconate were added to tap water with respect to the weight of the tap water (the amount of sodium gluconate added thereto corresponds to 0.5% thereof added to feed).
- The standard test feed for chickens (SDB No. 1 and SDB No. 2, standard test feeds for broilers, manufactured by Nippon Haigo Shiryo) itself was used as feed. Of the standard test feed for broilers, SDB No. 1 (this is for the former stage in raising broilers) and SDB No. 2 (this is for the latter stage in raising broilers) both contained 0.1% of sodium gluconate.
- The feeds of Example 10 and Comparative Example 4 and the drinking water prepared in Example 11 were fed to groups of new born broiler chicks (Chunky), each group being composed of 50 chicks (25 male chicks and 25 female chicks), continuously for 8 weeks. At the start of the feeding test, on two weeks, 4 weeks and 6 weeks after the start of the test, and at the end of the test, that is, five times in all, the chicks were weighed individually, and an increase in the body weight was calculated for every group. In each group, checked was the feed intake during the period between the days on which the body weight was measured, and the feed conversion ratio was calculated from the overall body weight increase and the overall feed intake. The results are shown in Table 3.
TABLE 3 Amount of Mean Body Sodium Weight Increase Mean Feed Gluconate Added (g) Conversion Ratio (%) (index*) (index*) Example 10 in feed, 0.5 2847 (110) 2.05 (94) Example 11 in drinking water, 2597 (106) 2.03 (94) 0.14 Comparative in feed, 0 2460 (100) 2.17 (100) Example 4
*Index based on Comparative Example 4 of 100.
- As shown in Table 3, in the cases where the chicks were fed with the feed that contained from 0.5% of sodium gluconate and the drinking water that contained 0.14% of sodium gluconate, the body weight of the chicks increased by 6 to 10% and the feed efficiency improved by 6%, as compared with the cases of the chicks not having taken sodium gluconate.
- To a feed for latter artificial milk suckling-stage piglets (manufactured by Nippon Kagaku Shiryo Kyokai) and to a feed for raising piglets (manufactured by Nippon Kagaku Shiryo Kyokai), added were 0.05, 0.1, 0.25, 0.5 and 1.0%, relative to the weight of the feeds, of sodium gluconate.
- The above-mentioned feeds were fed to groups of piglets (body weight: about 20 kg), each group being composed of 4 piglets (2 male piglets and 2 female piglets), continuously for 8 weeks (the feed for latter artificial milk for the former 2 weeks and the feed for raising piglets for the latter 6 weeks). During the period of the feeding test, each of the piglets was weighed every week, and an increase in the body weight was calculated for every group. In each group, checked was the feed intake during the period between the days on which the body weight was measured, and the feed conversion ratio was calculated.
- This test was repeated 10 times for the group not having taken sodium gluconate and the group having taken 0.5% sodium gluconate, but 5 times for the other groups having taken sodium gluconate in different concentrations. The obtained body weight increases and the feed conversion ratios were averaged for every group. The results are shown in Table 4 and
FIG. 2 .TABLE 4 Body Weight Feed Amount of Increase Conversion Additive Test Cycle (kg) ± S.D. Ratio ± S.D. Added (%) Frequency (index %) (index %) Control with — 10 38.46 ± 4.44 2.70 ± 0.14 no additive (100) (100) Sodium 0.05 5 39.96 ± 5.83 2.62 ± 0.15 Gluconate (104) (97) Added 0.1 5 40.92 ± 4.49 2.58 ± 0.11 (106) (96) 0.25 5 41.26 ± 3.44 2.55 ± 0.17 (107) (94) 0.5 10 40.43 ± 4.40 2.63 ± 0.12 (105) (97) 1.0 5 39.28 ± 2.58 2.74 ± 0.05 (102) (101) - As shown in the results, in the cases where the piglets were fed with the feeds containing 0.05 to 1.0 wt % of sodium gluconate, the body weight of the piglets increased by 2 to 7%, and the feed conversion ratio improved by 3 to 6%, as compared with the case where sodium gluconate was not added to the feeds.
- Three pigs were acclimated for 1 week, and the contents of their large intestines were taken out. The contents were diluted 5-fold with an anaerobic phosphate buffer (50 mM, pH 6.5), and then filtrated through 4-layered gauze. 25 mL of the resulting filtrate was put into serum bottles of 120 mL volume, and the gas phase therein was purged with a mixed gas of nitrogen/carbon dioxide (80/20). The bottles were sealed with butyl rubber stoppers and aluminum seals, and left for static culture at 39° C. for 24 hours (n=3).
- Prior to putting the intestinal filtrate into the serum bottles, 1 w/v % glucose (positive control) and 1 w/v % sodium gluconate were put in the bottles, except for an additive-free control (negative control).
- After the intestinal filtrate was thus cultivated, 1 mL of 6 N hydrochloric acid was added thereto to stop fermentation. The resulting cultures were analyzed as follows:
- The cultures were pre-treated according to the Ushida and Sakata's conditions (Anim. Sci. Technol., 69, 571-575, 1988), and then were analyzed on the concentration of short-chain fatty acids, succinic acid and lactic acid therein by HPLC and the concentration of ammonia therein by the indophenol method (Weatherburn, Analytic Chem., 39, 971-974, 1967). Subtracting the concentration before cultivation from that after cultivation gives the amount (mM) generated through fermentation. The results are shown in Table 5.
TABLE 5 (mM) Propionic Succinic Acid Lactic Acid Acetic Acid Acid Butyric Acid Ammonia Before Cultivation 0.17 (100) 3.37 (100) 40.06 (100) 10.97 (100) 5.39 (100) 7.83 (100) After Control with 0 (0) 0.16 (5) 69.27 (173) 26.08 (238) 8.97 (166) 28.81 (368) Cultivation no additive Sodium 0 (0) 0 (0) 161.90 (404) 103.25 (941) 70.36 (1305) 5.79 (74) Gluconate added Glucose 1.26 (741) 58.31 (173) 119.04 (297) 111.48 (1016) 35.08 (651) 4.82 (62) added
* The data parenthesized indicate the index based on the data before cultivation of 100.
- As shown in Table 5, the concentration of acetic acid, propionic acid and butyric acid in the cultures with sodium gluconate added thereto greatly increased as compared with that in the cultures without sodium gluconate. This increase is comparable or higher as compared with the cultures with glucose added thereto, and in particular, butyric acid was observed to increase significant. Substances which may be harmful such as lactic acid, succinic acid and ammonia were observed to greatly reduce in the cultures with sodium gluconate added thereto.
- The amount of fermentation gas generated in the cultivation of Example 12 was measured by putting a glass syringe equipped with an injection needle into a head space of the serum bottle, sucking the gas until normal pressure is reached and measuring the sucked gas by a syringe scale.
- The composition of the gas was analyzed for carbon dioxide, methane, hydrogen and hydrogen sulfide by TCD and FPD gas chromatography (Ushida, et al.; Jpn. J. Zootech. Sci., 53, 412-416, 1982, and Anim. Sci. Technol., 69, 571-575, 1998). The results are shown in Table 6 (n=3, μL/g).
TABLE 6 (μL/g) Carbon Hydrogen Total Gas Dioxide Hydrogen Methane Sulfide Control 2620 420 9.84 10 3.29 with no additive Sodium 6880 4330 211.99 30 0.09 Gluconate added Glucose 4800 2180 228.53 0 0.29 added - As shown in Table 6, hydrogen sulfide, a harmful substance, greatly reduced in the cultures with sodium gluconate added thereto, as compared with the case of the cultures with no additives. The increased amount of generated hydrogen and methane suggests active anaerobic fermentation by microorganisms.
- Pigs were acclimated for 1 week, and the contents of their large intestines were taken out. The contents were diluted 5-fold with an anaerobic phosphate buffer (50 mM, pH 6.5), and then filtrated through 4-layered gauze. One mL of the resulting filtrate was inoculated on a PYF medium (100 mL) with 1 w/v % sodium gluconate added thereto, and incubated in an anaerobic condition at 39° C.
- During incubation, 5 mL of a sterilized 10 w/v % aqueous solution of sodium gluconate were put into the medium at intervals of 48 hours.
- The culture without sodium gluconate and the culture with sodium gluconate added thereto were sampled on 0, 8, 24, 48, 96 and 144 hours in a germ-free condition, and the samples were diluted to 10−5. 0.05 mL of each dilution were inoculated on BL agar media (manufactured by Nissui), and anaerobically incubated at 37° C. for 48 hours. The number of colonies of anaerobic microorganisms having grown in agar plates was counted (Table 7).
- At the same time, according to the properties of the colonies thus grown, strains having grown only on the agar plate inoculated with the 144-hour sample of sodium gluconate-added culture were isolated, and they were counted and identified (Table 8).
TABLE 7 (data: logarithmic number of the cells in 1 g of culture) Time after Start of Incubation (hrs) 0 8 24 48 96 144 Control with no additive <6.3 8.3 9.3 8.3 8.4 7.4 Sodium <6.3 8.9 10.7 8.7 10.4 7.7 Gluconate added -
TABLE 8 (data: logarithmic number of the cells in 1 g of culture) Control with no additive Sodium Gluconate added Megasphaera elsdenii <6.3 6.4 Mitsuokella multiacidus <6.3 7.2 - As shown in Tables 7 and 8, the addition of sodium gluconate increased the total number of anaerobic microorganisms. In particular, Megasphaera elsdenii and Mitsuokella multiacidus were observed to increase.
- The strains Megasphaera elsdenii and Mitsuokella multiacidus having grown in Example 14 were anaerobically incubated in PYF media (100 mL) with 1% w/v sodium gluconate added thereto, at 39° C. for 24 hours. The cultures were analyzed on the concentration of the short-chain fatty acids (mM) therein in the same manner as in Example 12. The results are shown in Table 9.
TABLE 9 (mM) Type of Propionic Butyric Enterobacteria Acetic Acid Acid Acid Megasphaera Control with no 5.8 1.6 1.4 elsdenii additive Sodium Gluconate 8.7 0.8 4.9 added Difference 2.9 −0.8 3.5 Mitsuokella Control with no 2.9 7.0 0.3 multiacidus additive Sodium Gluconate 9.9 43.1 1.0 added Difference 7.0 36.1 0.7 - As shown in Table 9, it was confirmed that the two species of enterobacteria utilized sodium gluconate to produce various short-chain fatty acids. In particular, Megasphaera elsdenii produced a lot of acetic acid and butyric acid, and Mitsuokella multiacidus produced a lot of acetic acid and propionic acid.
- The present invention provides an agent for promoting the fattening of animals, which contains, as the active ingredient, at least one of hexose-derived acids and their non-toxic salts and intramolecular ester compounds and also provides a method for promoting the fattening of animals by use of the promoting agent.
- The promoting agent increases enterobacteria, thereby inducing the production only of short-chain fatty acids that are useful for the growth of living things. Consequently, even a poorly-nutritious feed can attain the same level of feed efficiency as that of highly-nutritious feed, and the fattening of animals can be promoted.
Claims (17)
1-17. (canceled)
18. A composition comprising at least one compound selected from the group consisting of gluconic acid, allonic acid, talonic acid, mannoic acid, galactonic acid, idalic acid, gularic acid, mannaric acid, glucaric acid, glucono delta lactone, and glucono gamma lactone, and non-toxic salts thereof, and at least one enterobacterium selected from the group consisting of Megasphaera and Mitsuokella.
19. The composition of claim 18 , comprising gluconic acid.
20. The composition of claim 18 , comprising glucono delta lactone.
21. The composition of claim 18 , comprising at least one non-toxic salt of gluconic acid selected from the group consisting of an alkali metal salt, an alkaline earth metal salt, and a transition metal salt.
22. The composition of claim 21 , wherein the at least one non-toxic salt of gluconic acid is selected from the group consisting of sodium gluconate, potassium gluconate, calcium gluconate, magnesium gluconate, copper gluconate, iron gluconate, and zinc gluconate.
23. The composition of claim 18 , comprising sodium gluconate.
24. The composition of claim 18 , comprising calcium gluconate.
25. The composition of claim 18 , comprising Megasphaera.
26. The composition of claim 18 , comprising Megasphaera elsdenii.
27. The composition of claim 18 , comprising Mitsuokella.
28. The composition of claim 18 , comprising Mitsuokella multiacidus.
29. The composition of claim 18 , further comprising at least one additive selected from the group consisting of at least one antibacterial agent, at least one antifungal agent, at least one antihelminthic agent, at least one antioxidant, at least one dye, at least one flavoring, at least one seasoning, and at least one enzyme.
30. The composition of claim 18 , further comprising an at least one vehicle selected from the group consisting of lactose, sucrose, glucose, corn starch, gelatin, starch, water, glycerin, fatty oil, and sorbitol.
31. The composition of claim 18 , formulated as a liquid.
32. The composition of claim 18 , formulated as a solid.
33. The composition of claim 18 , further comprising at least one feed selected from the group consisting of corn, rice, barley, wheat, milo, soybean refuse, cereal bran, defatted rice bran, fish meal, skim milk, dry whey, oil, fat, alfalfa, meal, northern-sea meal, soybean oil, soybean fat, dried pure beef tallow, wheat flour, rapeseed oil, rapeseed fat, feather meal, animal oil, animal fat, calcium phosphate, corn gluten meal, molasses, corn germ meal, calcium carbonate, tricalcium phosphate, sodium chloride, choline chloride, at least one vitamin, at least one minor inorganic salt, and at least one living microorganism.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/341,448 US20060128795A1 (en) | 1999-10-19 | 2006-01-30 | Agents for promoting fattening of animals and method of promoting fattening |
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP29672599 | 1999-10-19 | ||
| JP11-296725 | 1999-10-19 | ||
| PCT/JP2000/007237 WO2001028551A1 (en) | 1999-10-19 | 2000-10-18 | Agents for promoting fattening of animals and method of promoting fattening |
| US10/110,215 US6718910B1 (en) | 1999-10-19 | 2000-10-18 | Agents for promoting fattening of animals and method of promoting fattening |
| US10/769,849 US7186544B2 (en) | 1999-10-19 | 2004-02-03 | Agents for promoting fattening of animals and method of promoting fattening |
| US11/341,448 US20060128795A1 (en) | 1999-10-19 | 2006-01-30 | Agents for promoting fattening of animals and method of promoting fattening |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US10/769,849 Division US7186544B2 (en) | 1999-10-19 | 2004-02-03 | Agents for promoting fattening of animals and method of promoting fattening |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20060128795A1 true US20060128795A1 (en) | 2006-06-15 |
Family
ID=17837296
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US10/110,215 Expired - Fee Related US6718910B1 (en) | 1999-10-19 | 2000-10-18 | Agents for promoting fattening of animals and method of promoting fattening |
| US10/769,849 Expired - Fee Related US7186544B2 (en) | 1999-10-19 | 2004-02-03 | Agents for promoting fattening of animals and method of promoting fattening |
| US11/341,448 Abandoned US20060128795A1 (en) | 1999-10-19 | 2006-01-30 | Agents for promoting fattening of animals and method of promoting fattening |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US10/110,215 Expired - Fee Related US6718910B1 (en) | 1999-10-19 | 2000-10-18 | Agents for promoting fattening of animals and method of promoting fattening |
| US10/769,849 Expired - Fee Related US7186544B2 (en) | 1999-10-19 | 2004-02-03 | Agents for promoting fattening of animals and method of promoting fattening |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US6718910B1 (en) |
| EP (1) | EP1230922B9 (en) |
| KR (1) | KR20020060199A (en) |
| CN (3) | CN100353937C (en) |
| AR (1) | AR026895A1 (en) |
| AT (1) | ATE347884T1 (en) |
| AU (1) | AU784022B2 (en) |
| BR (1) | BR0015060A (en) |
| CA (1) | CA2388244C (en) |
| DE (1) | DE60032383T2 (en) |
| NZ (1) | NZ518757A (en) |
| WO (1) | WO2001028551A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8536106B2 (en) | 2010-04-14 | 2013-09-17 | Ecolab Usa Inc. | Ferric hydroxycarboxylate as a builder |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2002058483A1 (en) * | 2001-01-24 | 2004-05-27 | 藤沢薬品工業株式会社 | Milk ingredient improver and meat quality improver for animals containing hexose-derived acid |
| US8034372B2 (en) * | 2003-03-05 | 2011-10-11 | Nestec, Ltd. | Dietary supplement for athletic pets |
| US7655678B2 (en) * | 2004-11-30 | 2010-02-02 | Council of Scientfic & Industrial Research | Pharmaceutical composition for the management of tumors |
| CN101209084B (en) * | 2006-12-26 | 2011-03-30 | 河南农业大学 | A kind of pet drink containing active peptide and its preparation method |
| JP5634261B2 (en) | 2008-06-09 | 2014-12-03 | 出光興産株式会社 | Feed composition and feed containing the same |
| CN102210282B (en) * | 2011-03-31 | 2013-05-01 | 郝英 | Method for fattening horses |
| BR112014022286B1 (en) * | 2012-03-09 | 2019-11-12 | Friesland Brands Bv | animal feed composition containing encapsulated delta-lactone gluconoid |
| CN103637000A (en) * | 2013-11-28 | 2014-03-19 | 吉林大学 | Mixed additive capable of promoting growth of poultry and application thereof |
| NZ730883A (en) | 2014-10-10 | 2022-10-28 | Nutreco Nederland Bv | Compositions to increase milk fat production in lactating ruminants and methods using the same |
| WO2020016272A1 (en) * | 2018-07-17 | 2020-01-23 | Nutreco Ip Assets B.V. | Methods to improve health and wellbeing in ruminants |
| EP4304387A1 (en) * | 2021-03-12 | 2024-01-17 | Nutreco IP Assets B.V. | Method of feeding a gestating animal |
Citations (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3939275A (en) * | 1972-03-06 | 1976-02-17 | Smithkline Corporation | Methods and compositions for increasing growth rate and feed efficiency of animals |
| US4001453A (en) * | 1973-10-05 | 1977-01-04 | Givaudan Corporation | Sweetening compositions |
| US4095000A (en) * | 1974-05-17 | 1978-06-13 | Max Brenner | Protein-saving foodstuff and fodder additive |
| US4138498A (en) * | 1976-12-07 | 1979-02-06 | W. R. Grace & Co. | Ruminant feed additive |
| US4164568A (en) * | 1976-03-27 | 1979-08-14 | Beechamgroup Limited | Oral scour formulations with citrate |
| US4234599A (en) * | 1978-10-04 | 1980-11-18 | Scott Eugene J Van | Treatment of skin keratoses with α-hydroxy acids and related compounds |
| US4353902A (en) * | 1980-09-22 | 1982-10-12 | Smithkline Corporation | Livestock feed and method for improving food utilization |
| US4362710A (en) * | 1980-07-04 | 1982-12-07 | Nissan Gosei Kogyo Co., Ltd. | Feeds for baby pigs, process for preparing the same and method of breeding baby pigs |
| US4504471A (en) * | 1982-09-27 | 1985-03-12 | Fujisawa Pharmaceutical Co., Ltd. | Animal growth promotant and method of use for animal growth |
| US4528197A (en) * | 1983-01-26 | 1985-07-09 | Kabivitrum Ab | Controlled triglyceride nutrition for hypercatabolic mammals |
| US4559234A (en) * | 1984-05-30 | 1985-12-17 | Canadian Patents And Development Limited | Meat curing compositions and method of use |
| US4647453A (en) * | 1984-10-18 | 1987-03-03 | Peritain, Ltd. | Treatment for tissue degenerative inflammatory disease |
| US4869907A (en) * | 1984-04-18 | 1989-09-26 | Toyo Jozo Kabushiki Kaisha | Method of enhancing growth and weight gain in swine and block for use therein |
| US4954355A (en) * | 1987-03-30 | 1990-09-04 | Asko Haarasilta | Feed raw material and feed containing zero fibre and procedure for producing these |
| US5364788A (en) * | 1991-07-01 | 1994-11-15 | Ahc Inc. | Pure culture of Bacillus subtilis FERM BP-3418 |
| US5462967A (en) * | 1991-06-17 | 1995-10-31 | Kao Corporation | Feed additive for livestock and feed for livestock |
| US5529793A (en) * | 1994-11-16 | 1996-06-25 | Nutrition Physiology Corporation | Compositions for improving the utilization of feedstuffs by ruminants |
| US5534271A (en) * | 1994-11-16 | 1996-07-09 | Nutrition Physiology | Process for improving the utilization of feedstuffs by ruminants |
| US5605697A (en) * | 1992-10-27 | 1997-02-25 | Fujisawa Pharmaceutical Co., Ltd. | Bifidobacterium growth promotant |
| US5997911A (en) * | 1996-08-27 | 1999-12-07 | Brinton Veterinary Supply, Inc. | Composition and method for reducing diarrhea in poultry and swine |
| US6387419B1 (en) * | 1998-06-02 | 2002-05-14 | Biofiber-Damino A/S | Piglet feeding method |
| US6455063B1 (en) * | 1998-04-17 | 2002-09-24 | The Board Of Regents For Oklahoma State University | Propionibacterium P-63 for use in direct fed microbials for animal feeds |
| US6506402B1 (en) * | 1998-10-05 | 2003-01-14 | Pennfield Oil Company | Chlortetracycline-containing animal feed compositions and methods for their use |
| US20040120963A1 (en) * | 2001-04-06 | 2004-06-24 | Kazunari Ushida | Compositions containing bacterium capable of converting lactic acid into butyric acid and method of preventing/treating hyperlactic acidemia in digestive tract and colon cancer by using the same |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5398287A (en) * | 1977-01-27 | 1978-08-28 | Masaji Kimura | Method for producing synthetic feed for sericulture culture etc |
| JPS56121456A (en) * | 1980-02-25 | 1981-09-24 | Tsukubane Shokuhin Kogyo Kk | Preparation of sauce |
| JPS56121436A (en) | 1980-02-29 | 1981-09-24 | Kyodo Shiryo Kk | Formula stock feed |
| US4362712A (en) * | 1980-07-25 | 1982-12-07 | Johnson & Johnson Products, Inc. | Carboxylated naphthalene formaldehyde condensation polymers as dental plaque barriers |
| JPS60164442A (en) * | 1984-02-04 | 1985-08-27 | Jun Kawai | Preparation of feed |
| JP2582092B2 (en) * | 1987-10-09 | 1997-02-19 | 明治乳業株式会社 | Livestock and poultry feed composition |
| FI882900L (en) * | 1988-06-16 | 1989-12-17 | Cultor Oy | FODER OCH FOERFARANDE FOER GRANULERING AV DETSAMMA. |
| FI86134C (en) | 1989-03-03 | 1993-06-08 | Cultor Oy | Mineral processing and production For the production of water |
| GB8922018D0 (en) * | 1989-09-29 | 1989-11-15 | Unilever Plc | Detergent compositions and process for preparing them |
| NZ241426A (en) * | 1992-01-28 | 1995-07-26 | Kiwi Co Op Dairies Ltd | Abalone feed composition containing casein and acidity adjusters providing for good extrusion and stability in sea water |
| JP3067901B2 (en) | 1992-08-10 | 2000-07-24 | ダイセル化学工業株式会社 | Method for producing optically active 2-hydroxy-4-phenyl-3-butenoic acid |
| US5445560A (en) | 1994-02-09 | 1995-08-29 | Teepak, Inc. | Hybrid end closure for shirred food casing |
| JPH11289996A (en) * | 1998-04-08 | 1999-10-26 | Agriculture Forestry And Fisheries Technical Information Society | Growth promoter |
-
2000
- 2000-10-18 CN CNB200510071205XA patent/CN100353937C/en not_active Expired - Fee Related
- 2000-10-18 NZ NZ518757A patent/NZ518757A/en unknown
- 2000-10-18 WO PCT/JP2000/007237 patent/WO2001028551A1/en not_active Ceased
- 2000-10-18 AT AT00969858T patent/ATE347884T1/en not_active IP Right Cessation
- 2000-10-18 CA CA002388244A patent/CA2388244C/en not_active Expired - Fee Related
- 2000-10-18 EP EP00969858A patent/EP1230922B9/en not_active Expired - Lifetime
- 2000-10-18 DE DE60032383T patent/DE60032383T2/en not_active Expired - Fee Related
- 2000-10-18 AU AU79482/00A patent/AU784022B2/en not_active Withdrawn - After Issue
- 2000-10-18 US US10/110,215 patent/US6718910B1/en not_active Expired - Fee Related
- 2000-10-18 BR BR0015060-6A patent/BR0015060A/en not_active IP Right Cessation
- 2000-10-18 CN CNB2005100712100A patent/CN100548144C/en not_active Expired - Fee Related
- 2000-10-18 KR KR1020027004849A patent/KR20020060199A/en not_active Ceased
- 2000-10-18 CN CN00817058A patent/CN1409629A/en active Pending
- 2000-10-19 AR ARP000105507A patent/AR026895A1/en unknown
-
2004
- 2004-02-03 US US10/769,849 patent/US7186544B2/en not_active Expired - Fee Related
-
2006
- 2006-01-30 US US11/341,448 patent/US20060128795A1/en not_active Abandoned
Patent Citations (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3939275A (en) * | 1972-03-06 | 1976-02-17 | Smithkline Corporation | Methods and compositions for increasing growth rate and feed efficiency of animals |
| US4001453A (en) * | 1973-10-05 | 1977-01-04 | Givaudan Corporation | Sweetening compositions |
| US4095000A (en) * | 1974-05-17 | 1978-06-13 | Max Brenner | Protein-saving foodstuff and fodder additive |
| US4164568A (en) * | 1976-03-27 | 1979-08-14 | Beechamgroup Limited | Oral scour formulations with citrate |
| US4138498A (en) * | 1976-12-07 | 1979-02-06 | W. R. Grace & Co. | Ruminant feed additive |
| US4234599A (en) * | 1978-10-04 | 1980-11-18 | Scott Eugene J Van | Treatment of skin keratoses with α-hydroxy acids and related compounds |
| US4362710A (en) * | 1980-07-04 | 1982-12-07 | Nissan Gosei Kogyo Co., Ltd. | Feeds for baby pigs, process for preparing the same and method of breeding baby pigs |
| US4353902A (en) * | 1980-09-22 | 1982-10-12 | Smithkline Corporation | Livestock feed and method for improving food utilization |
| US4504471A (en) * | 1982-09-27 | 1985-03-12 | Fujisawa Pharmaceutical Co., Ltd. | Animal growth promotant and method of use for animal growth |
| US4528197A (en) * | 1983-01-26 | 1985-07-09 | Kabivitrum Ab | Controlled triglyceride nutrition for hypercatabolic mammals |
| US4869907A (en) * | 1984-04-18 | 1989-09-26 | Toyo Jozo Kabushiki Kaisha | Method of enhancing growth and weight gain in swine and block for use therein |
| US4960589A (en) * | 1984-04-18 | 1990-10-02 | Toyo Jozo Kabushiki Kaisha | Method of enhancing growth and improving feed conversion ratio in animals and block for use therein |
| US4559234A (en) * | 1984-05-30 | 1985-12-17 | Canadian Patents And Development Limited | Meat curing compositions and method of use |
| US4647453A (en) * | 1984-10-18 | 1987-03-03 | Peritain, Ltd. | Treatment for tissue degenerative inflammatory disease |
| US4954355A (en) * | 1987-03-30 | 1990-09-04 | Asko Haarasilta | Feed raw material and feed containing zero fibre and procedure for producing these |
| US5462967A (en) * | 1991-06-17 | 1995-10-31 | Kao Corporation | Feed additive for livestock and feed for livestock |
| US5549890A (en) * | 1991-07-01 | 1996-08-27 | Ahc, Inc. | Animal feed containing Bacillus subtilis FERM BP-3418 that decomposes aflatoxin |
| US5364788A (en) * | 1991-07-01 | 1994-11-15 | Ahc Inc. | Pure culture of Bacillus subtilis FERM BP-3418 |
| US5605697A (en) * | 1992-10-27 | 1997-02-25 | Fujisawa Pharmaceutical Co., Ltd. | Bifidobacterium growth promotant |
| US5534271A (en) * | 1994-11-16 | 1996-07-09 | Nutrition Physiology | Process for improving the utilization of feedstuffs by ruminants |
| US5529793A (en) * | 1994-11-16 | 1996-06-25 | Nutrition Physiology Corporation | Compositions for improving the utilization of feedstuffs by ruminants |
| US5997911A (en) * | 1996-08-27 | 1999-12-07 | Brinton Veterinary Supply, Inc. | Composition and method for reducing diarrhea in poultry and swine |
| US6455063B1 (en) * | 1998-04-17 | 2002-09-24 | The Board Of Regents For Oklahoma State University | Propionibacterium P-63 for use in direct fed microbials for animal feeds |
| US6387419B1 (en) * | 1998-06-02 | 2002-05-14 | Biofiber-Damino A/S | Piglet feeding method |
| US6506402B1 (en) * | 1998-10-05 | 2003-01-14 | Pennfield Oil Company | Chlortetracycline-containing animal feed compositions and methods for their use |
| US20040120963A1 (en) * | 2001-04-06 | 2004-06-24 | Kazunari Ushida | Compositions containing bacterium capable of converting lactic acid into butyric acid and method of preventing/treating hyperlactic acidemia in digestive tract and colon cancer by using the same |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8536106B2 (en) | 2010-04-14 | 2013-09-17 | Ecolab Usa Inc. | Ferric hydroxycarboxylate as a builder |
| US9023780B2 (en) | 2010-04-14 | 2015-05-05 | Ecolab Usa Inc. | Ferric hydroxycarboxylate as a builder |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1230922B9 (en) | 2007-02-21 |
| CA2388244A1 (en) | 2001-04-26 |
| CN100353937C (en) | 2007-12-12 |
| CN1409629A (en) | 2003-04-09 |
| WO2001028551A1 (en) | 2001-04-26 |
| US7186544B2 (en) | 2007-03-06 |
| CN1689431A (en) | 2005-11-02 |
| EP1230922A1 (en) | 2002-08-14 |
| US20040156855A1 (en) | 2004-08-12 |
| AU7948200A (en) | 2001-04-30 |
| NZ518757A (en) | 2006-06-30 |
| EP1230922B1 (en) | 2006-12-13 |
| BR0015060A (en) | 2002-07-23 |
| ATE347884T1 (en) | 2007-01-15 |
| EP1230922A4 (en) | 2003-01-29 |
| DE60032383D1 (en) | 2007-01-25 |
| AR026895A1 (en) | 2003-03-05 |
| WO2001028551A9 (en) | 2002-07-04 |
| DE60032383T2 (en) | 2007-03-29 |
| US6718910B1 (en) | 2004-04-13 |
| CN100548144C (en) | 2009-10-14 |
| AU784022B2 (en) | 2006-01-19 |
| KR20020060199A (en) | 2002-07-16 |
| CA2388244C (en) | 2009-02-03 |
| CN1689560A (en) | 2005-11-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11517551B2 (en) | Lactylates for the prevention and treatment of infections caused by gram-positive bacteria in animals | |
| US20010043983A1 (en) | Nutritional supplements for aged pets | |
| JP2003535894A (en) | Medium-chain fatty acids applicable as antibacterial agents | |
| US7186544B2 (en) | Agents for promoting fattening of animals and method of promoting fattening | |
| JP2001169731A (en) | Lipid metabolism improving agent for animal | |
| EP1389464A1 (en) | Compositions containing bacterium capable of converting lactic acid into butyric acid and method of preventing/treating hyperlactic acidemia in digestive tract and colon cancer by using the same | |
| AU2005248934B2 (en) | Agents for promoting fattening of animals and method of promoting fattening | |
| JP2003088301A (en) | Composition for suppressing methane production and feed composition for ruminants | |
| EP3838347B1 (en) | Evernimicin for treating diseases like necrotic enteritis | |
| JPWO2001028551A1 (en) | Animal fattening promoter and fattening promotion method | |
| Warden et al. | Effect of feeding Escherichia coli to turkey poults and chicks in the presence of certain antibiotics | |
| JPH08245396A (en) | Agent for anticholesterol | |
| JPS61224918A (en) | Composition for pretreating fish diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |